Phase 2 Readout
TYRA: Phase 2 Readout: tyra-300
June 30, 2026 · tyra-300. BioSniper AI can trace the company-impact path without requiring you to write the research question.
- Event date
- June 30, 2026
- Company
- Tyra Biosciences, Inc. (TYRA)
- Drug
- tyra-300
BioSniper AIPage evidence connected
Prepared research question
What could this event change, and which evidence should be watched next?
Run cited research
Traceable citations · Unknowns marked
Phase 2 Readout~quarter
Phase 2 Readout: tyra-300
- Drug
- tyra-300
- Indication
- low-grade, intermediate risk non-muscle invasive bladder cancer (IR NMIBC)